Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer
Version 2 2024-06-04, 06:22Version 2 2024-06-04, 06:22
Version 1 2017-09-01, 00:00Version 1 2017-09-01, 00:00
journal contribution
posted on 2024-06-04, 06:22 authored by G Turine, A Peeters, C Hermans, S Eeckhoudt, T DuprezIntravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer
History
Related Materials
- 1.
Location
Heidelberg, GermanyLanguage
engPublication classification
C4 Letter or noteCopyright notice
2017, Belgian Neurological SocietyJournal
Acta Neurologica BelgicaVolume
117Pagination
753-755ISSN
0300-9009eISSN
2240-2993Issue
3Publisher
SpringerUsage metrics
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC

